Black Diamond Therapeutics Inc. (BDTX) Social Stream
BLACK DIAMOND THERAPEUTICS INC (BDTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BLACK DIAMOND THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 3 | $53 | $10 | $26.6 | $3.04 | 775% |
| 2022-03-17 | 6 | $53 | $4 | $25.4 | $3.04 | 735.53% |
| 2022-03-29 | 6 | $33 | $4 | $14 | $3.04 | 360.53% |
| 2022-03-30 | 6 | $33 | $4 | $12 | $3.04 | 294.74% |
| 2022-05-11 | 6 | $9 | $4 | $6 | $3.04 | 97.37% |
| 2022-05-12 | 6 | $9 | $3 | $5.75 | $3.04 | 89.14% |
| 2022-08-10 | 5 | $9 | $3 | $5.333 | $3.04 | 75.43% |
| 2022-11-08 | 5 | $5 | $3 | $4 | $3.04 | 31.58% |
| 2022-12-20 | 5 | $5 | $3 | $3.666 | $3.04 | 20.59% |
| 2023-03-09 | 4 | $5 | $3 | $3.666 | $3.04 | 20.59% |
| 2023-05-09 | 5 | $5 | $2 | $3.333 | $3.04 | 9.64% |
| 2023-06-28 | 5 | $11 | $2 | $8.25 | $3.04 | 171.38% |
| 2023-06-30 | 6 | $11 | $10 | $10.25 | $3.04 | 237.17% |
| 2023-11-22 | 6 | $11 | $10 | $10.4 | $3.04 | 242.11% |
The Trend in the Analyst Price Target
Over the past 20 months, BDTX's average price target has gone down $15.
Over the past 37 weeks, BDTX's average upside potential has been 203.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 5 | 5 | 2 | 3.333 | 1.45 | 129.86% |
| 2023-03-09 | 4 | 5 | 2 | 3.333 | 1.45 | 129.86% |
| 2023-05-09 | 5 | 5 | 2 | 3.333 | 1.82 | 83.13% |
| 2023-06-28 | 5 | 11 | 2 | 8.250 | 5.73 | 43.98% |
| 2023-08-14 | 6 | 11 | 10 | 10.400 | 3.29 | 216.11% |
BDTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 153 days, BDTX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BDTX as an investment opportunity.
- In terms of how BLACK DIAMOND THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1416.04% of that group.
- In the context of all US stocks, BLACK DIAMOND THERAPEUTICS INC's average analyst price target is greater than 284.36% of them.
- To contextualize these metrics, consider that out of all US stocks, BLACK DIAMOND THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1580.68% of them.
- In the context of Healthcare stocks, BLACK DIAMOND THERAPEUTICS INC's number of analysts covering the stock is greater than 564.5% of them.
In the Pharmaceutical Products industry, JSPR, CABA, and AVRO are the three stocks most similar to BLACK DIAMOND THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding BDTX using the data that counts. Try POWR Ratings for free.